Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) is a leading biotechnology company focused on acquiring, developing and commercializing drug products. The company currently markets five hematology/oncology drugs, and it expects an FDA decision on another hematology drug later this year. Additionally, Spectrum’s pipeline includes three drug candidates in advanced stages of clinical development targeting blockbuster markets. The company’s expertise in clinical development has helped it generate a robust, diversified and growing pipeline of product candidates in advanced-stage clinical studies. For more information, visit the company’s website at www.sppirx.com.